Coeptis Therapeutics Hldgs Inc (COEP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 1,363 | 0 | 0 | 0 | 75 |
| Cost of Goods | 181 | 0 | N/A | N/A | N/A |
| Gross Profit | 1,182 | 0 | N/A | N/A | 75 |
| Operating Expenses | 14,407 | 10,055 | 21,491 | 34,196 | 14,121 |
| Operating Income | -13,044 | -10,055 | -21,491 | -34,196 | -14,046 |
| Interest Expense | 97 | 246 | 108 | 218 | 187 |
| Other Income | 863 | -577 | 332 | -3,160 | 784 |
| Pre-tax Income | -12,277 | -10,877 | -21,267 | -37,574 | -13,449 |
| Net Income Continuous | -12,277 | -10,877 | -21,267 | -37,574 | -13,449 |
| Minority Interests | -360 | -197 | N/A | N/A | N/A |
| Net Income | $-11,917 | $-10,681 | $-21,267 | $-37,574 | $-13,449 |
| EPS Basic Total Ops | -2.81 | -5.56 | -16.56 | -52.60 | -24.60 |
| EPS Basic Continuous Ops | -2.90 | -5.65 | -16.56 | -52.57 | -24.64 |
| EPS Diluted Total Ops | -2.81 | -5.56 | -16.56 | -52.60 | -24.60 |
| EPS Diluted Continuous Ops | -2.90 | -5.65 | -16.56 | -52.57 | -24.64 |
| EPS Diluted Before Non-Recurring Items | N/A | -5.65 | -17.80 | N/A | N/A |
| EBITDA(a) | $-11,317 | $-8,838 | $-20,490 | $-33,195 | $-13,599 |